Corrigendum: DCBLD1 Overexpression is associated with a poor prognosis in head and neck squamous cell carcinoma

Standard

Corrigendum: DCBLD1 Overexpression is associated with a poor prognosis in head and neck squamous cell carcinoma. / Fu, Ling-Ling; Yan, Ming; Ma, Min-Xian; Luo, Yi; Shao, Min; Gosau, Martin; Friedrich, Reinhard E; Vollkommer, Tobias; Feng, Hong-Chao; Smeets, Ralf.

In: FRONT IMMUNOL, Vol. 13, 2022, p. 1099835.

Research output: SCORING: Contribution to journalOther (editorial matter etc.)Research

Harvard

APA

Vancouver

Bibtex

@article{0d5a2755135545638d1b202109a762a0,
title = "Corrigendum: DCBLD1 Overexpression is associated with a poor prognosis in head and neck squamous cell carcinoma",
abstract = "[This corrects the article DOI: 10.3389/fimmu.2022.939344.].",
author = "Ling-Ling Fu and Ming Yan and Min-Xian Ma and Yi Luo and Min Shao and Martin Gosau and Friedrich, {Reinhard E} and Tobias Vollkommer and Hong-Chao Feng and Ralf Smeets",
note = "Copyright {\textcopyright} 2022 Fu, Yan, Ma, Luo, Shao, Gosau, Friedrich, Vollkommer, Feng and Smeets.",
year = "2022",
doi = "10.3389/fimmu.2022.1099835",
language = "English",
volume = "13",
pages = "1099835",
journal = "FRONT IMMUNOL",
issn = "1664-3224",
publisher = "Lausanne : Frontiers Research Foundation",

}

RIS

TY - JOUR

T1 - Corrigendum: DCBLD1 Overexpression is associated with a poor prognosis in head and neck squamous cell carcinoma

AU - Fu, Ling-Ling

AU - Yan, Ming

AU - Ma, Min-Xian

AU - Luo, Yi

AU - Shao, Min

AU - Gosau, Martin

AU - Friedrich, Reinhard E

AU - Vollkommer, Tobias

AU - Feng, Hong-Chao

AU - Smeets, Ralf

N1 - Copyright © 2022 Fu, Yan, Ma, Luo, Shao, Gosau, Friedrich, Vollkommer, Feng and Smeets.

PY - 2022

Y1 - 2022

N2 - [This corrects the article DOI: 10.3389/fimmu.2022.939344.].

AB - [This corrects the article DOI: 10.3389/fimmu.2022.939344.].

U2 - 10.3389/fimmu.2022.1099835

DO - 10.3389/fimmu.2022.1099835

M3 - Other (editorial matter etc.)

C2 - 36505490

VL - 13

SP - 1099835

JO - FRONT IMMUNOL

JF - FRONT IMMUNOL

SN - 1664-3224

ER -